abstract |
The invention relates to novel cyclopeptides of the formula I cyclo-(Arg-A-Asp-R1-R2)Iin which A, R1 and R2 have the meaning given in claim 1, and their salts. These compounds act as integrin inhibitors and can be used in particular for the prophylaxis and treatment of disorders of the circulation, bones and in tumour therapy, and as antimicrobial and antiviral active compounds. |